Pages with the most revisions

Showing below up to 500 results in range #1 to #500.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

1. Cytomegalovirus‏‎ (67 revisions)
2. Mycobacterium tuberculosis‏‎ (62 revisions)
3. Infective endocarditis‏‎ (52 revisions)
4. SARS-CoV-2‏‎ (51 revisions)
5. Renal dosing of antimicrobials‏‎ (50 revisions)
6. Treponema pallidum pallidum‏‎ (45 revisions)
7. Epstein-Barr virus‏‎ (43 revisions)
8. Toxoplasma gondii‏‎ (39 revisions)
9. Hepatitis B virus‏‎ (39 revisions)
10. Streptococcus pyogenes‏‎ (39 revisions)
11. Pneumocystis jirovecii‏‎ (34 revisions)
12. Plasmodium‏‎ (33 revisions)
13. Aspergillus‏‎ (33 revisions)
14. Varicella-zoster virus‏‎ (32 revisions)
15. Staphylococcus aureus‏‎ (32 revisions)
16. Dosing of antimicrobials in obesity‏‎ (31 revisions)
17. Burkholderia pseudomallei‏‎ (31 revisions)
18. Tissue penetration of antimicrobials‏‎ (30 revisions)
19. Hepatitis C virus‏‎ (30 revisions)
20. Prosthetic joint infection‏‎ (30 revisions)
21. Neisseria gonorrhoeae‏‎ (30 revisions)
22. Infections after hematopoietic stem cell transplantation‏‎ (30 revisions)
23. Perinatal transmission of bloodborne infections‏‎ (30 revisions)
24. Primary immunodeficiency‏‎ (29 revisions)
25. Herpes simplex virus‏‎ (28 revisions)
26. Brucella melitensis‏‎ (27 revisions)
27. Enterococcus‏‎ (27 revisions)
28. Human immunodeficiency virus‏‎ (27 revisions)
29. Leptospira‏‎ (27 revisions)
30. Non-tuberculous mycobacteria‏‎ (27 revisions)
31. Welcome to the ID Wiki!‏‎ (27 revisions)
32. Invasive fungal infection‏‎ (27 revisions)
33. Pediatric dosing of antimicrobials‏‎ (27 revisions)
34. Pseudomonas aeruginosa‏‎ (26 revisions)
35. HIV medications‏‎ (26 revisions)
36. Clostridioides difficile‏‎ (26 revisions)
37. Tick-borne infections‏‎ (26 revisions)
38. Creutzfeldt-Jakob disease‏‎ (26 revisions)
39. Vancomycin‏‎ (24 revisions)
40. Rhodococcus hoagii‏‎ (24 revisions)
41. Streptococcus pneumoniae‏‎ (24 revisions)
42. Listeria monocytogenes‏‎ (24 revisions)
43. Infection control precautions by disease‏‎ (24 revisions)
44. Latent tuberculosis infection‏‎ (23 revisions)
45. Borrelia burgdorferi‏‎ (23 revisions)
46. Francisella tularensis‏‎ (22 revisions)
47. Mycobacterium leprae‏‎ (21 revisions)
48. Voriconazole‏‎ (21 revisions)
49. Cryptosporidium hominis‏‎ (21 revisions)
50. Osteomyelitis‏‎ (21 revisions)
51. Candida‏‎ (21 revisions)
52. Clostridium botulinum‏‎ (21 revisions)
53. Staphylococcus aureus bacteremia‏‎ (21 revisions)
54. Legionella‏‎ (20 revisions)
55. β-lactamases‏‎ (20 revisions)
56. Helminths‏‎ (20 revisions)
57. Echinococcus granulosus‏‎ (20 revisions)
58. Fever in a returned traveller‏‎ (20 revisions)
59. HIV treatment‏‎ (20 revisions)
60. Ehrlichia‏‎ (20 revisions)
61. Rickettsioses‏‎ (20 revisions)
62. Bacterial meningitis‏‎ (20 revisions)
63. Adverse drug reaction‏‎ (19 revisions)
64. Measles virus‏‎ (19 revisions)
65. Hyaline molds‏‎ (19 revisions)
66. Chlamydia trachomatis‏‎ (19 revisions)
67. Giardia lamblia‏‎ (19 revisions)
68. Taenia solium‏‎ (18 revisions)
69. Sporothrix schenckii‏‎ (18 revisions)
70. Enterobacteriaceae‏‎ (18 revisions)
71. Helicobacter pylori‏‎ (18 revisions)
72. Nodular lymphangitis‏‎ (18 revisions)
73. Corynebacterium diphtheriae‏‎ (18 revisions)
74. Opportunistic infections in HIV‏‎ (18 revisions)
75. Dimorphic fungi‏‎ (18 revisions)
76. Histoplasma capsulatum‏‎ (18 revisions)
77. Animal bite‏‎ (18 revisions)
78. Post-exposure prophylaxis for HIV‏‎ (17 revisions)
79. Pre-exposure prophylaxis for HIV‏‎ (17 revisions)
80. β-lactam allergy‏‎ (17 revisions)
81. Macacine alphaherpesvirus 1‏‎ (17 revisions)
82. Rickettsia‏‎ (17 revisions)
83. Vibrio‏‎ (17 revisions)
84. Congenital syphilis‏‎ (17 revisions)
85. Rickettsia typhi‏‎ (17 revisions)
86. Parasites‏‎ (16 revisions)
87. Campylobacter‏‎ (16 revisions)
88. Drug-resistant tuberculosis‏‎ (16 revisions)
89. β-lactam resistance‏‎ (16 revisions)
90. Nocardia‏‎ (16 revisions)
91. Stenotrophomonas maltophilia‏‎ (16 revisions)
92. Necrotizing soft tissue infection‏‎ (16 revisions)
93. Strongyloides stercoralis‏‎ (16 revisions)
94. Obligate anaerobes‏‎ (16 revisions)
95. Leuconostoc‏‎ (16 revisions)
96. Cellulitis‏‎ (16 revisions)
97. Pulmonary tuberculosis‏‎ (16 revisions)
98. Actinomycetes‏‎ (16 revisions)
99. Congenital CMV‏‎ (15 revisions)
100. Streptococcus bacteremia‏‎ (15 revisions)
101. Urinary tract infection‏‎ (15 revisions)
102. Aminoglycosides‏‎ (15 revisions)
103. Corynebacterium‏‎ (15 revisions)
104. Pantoea‏‎ (15 revisions)
105. Tuberculous meningitis‏‎ (15 revisions)
106. Streptobacillus moniliformis‏‎ (15 revisions)
107. Tick-borne relapsing fever‏‎ (15 revisions)
108. Brain abscess‏‎ (15 revisions)
109. Rickettsia rickettsii‏‎ (15 revisions)
110. Escherichia coli‏‎ (15 revisions)
111. Toxic shock syndrome‏‎ (15 revisions)
112. Carbapenemases‏‎ (15 revisions)
113. Mycobacterium avium complex‏‎ (14 revisions)
114. Intestinal protozoa‏‎ (14 revisions)
115. Fusobacterium‏‎ (14 revisions)
116. Blastomyces dermatitidis‏‎ (14 revisions)
117. Leishmania‏‎ (14 revisions)
118. Coagulase test‏‎ (14 revisions)
119. Infective Endocarditis in Adults (IDSA 2015)‏‎ (14 revisions)
120. Cyclospora cayetanensis‏‎ (14 revisions)
121. Echinococcus‏‎ (14 revisions)
122. Schistosoma‏‎ (14 revisions)
123. Aeromonas‏‎ (14 revisions)
124. Tick- and louse-borne relapsing fever‏‎ (14 revisions)
125. Neisseria meningitidis‏‎ (14 revisions)
126. Anaplasma phagocytophilum‏‎ (14 revisions)
127. Bordetella pertussis‏‎ (14 revisions)
128. Mpox virus‏‎ (14 revisions)
129. Mucorales‏‎ (13 revisions)
130. Herpes simplex encephalitis‏‎ (13 revisions)
131. Kaposi sarcoma‏‎ (13 revisions)
132. Fluconazole‏‎ (13 revisions)
133. HIV in pregnancy‏‎ (13 revisions)
134. Needlestick injuries and post-exposure prophylaxis‏‎ (13 revisions)
135. Intravascular catheter-related infections (IDSA 2009)‏‎ (13 revisions)
136. Erysipelothrix rhusiopathiae‏‎ (13 revisions)
137. Colistin‏‎ (13 revisions)
138. Immunization‏‎ (13 revisions)
139. Bartonella henselae‏‎ (13 revisions)
140. Coxiella burnetii‏‎ (13 revisions)
141. Liver abscess‏‎ (13 revisions)
142. Actinomyces‏‎ (13 revisions)
143. Chronic heart failure‏‎ (13 revisions)
144. Fungemia‏‎ (13 revisions)
145. Orientia tsutsugamushi‏‎ (13 revisions)
146. Citrobacter‏‎ (13 revisions)
147. Infection prevention and control program‏‎ (13 revisions)
148. Entamoeba histolytica‏‎ (13 revisions)
149. Enterobacter‏‎ (12 revisions)
150. Micrococcus‏‎ (12 revisions)
151. Campylobacter jejuni‏‎ (12 revisions)
152. Diarrhea in the returned traveller‏‎ (12 revisions)
153. Baltimore classification of viruses‏‎ (12 revisions)
154. Antibiotic prophylaxis for open fractures‏‎ (12 revisions)
155. Trimethoprim-sulfamethoxazole‏‎ (12 revisions)
156. Aseptic meningitis‏‎ (12 revisions)
157. Babesia microti‏‎ (12 revisions)
158. Initial assessment for patients with HIV‏‎ (12 revisions)
159. Bacillus anthracis‏‎ (12 revisions)
160. Community-acquired pneumonia‏‎ (12 revisions)
161. Streptococcus‏‎ (12 revisions)
162. Central line-associated bloodstream infection‏‎ (12 revisions)
163. Acanthamoeba‏‎ (12 revisions)
164. Enteric fever‏‎ (12 revisions)
165. Cryptococcus‏‎ (11 revisions)
166. Cutibacterium acnes‏‎ (11 revisions)
167. Gnathostoma‏‎ (11 revisions)
168. Aerococcus‏‎ (11 revisions)
169. Coccidioides immitis‏‎ (11 revisions)
170. Cardiovascular implantable electronic device infection‏‎ (11 revisions)
171. Echinococcus multilocularis‏‎ (11 revisions)
172. Rickettsia africae‏‎ (11 revisions)
173. Chikungunya virus‏‎ (11 revisions)
174. Stimulant use disorder‏‎ (11 revisions)
175. Cystoisospora belli‏‎ (11 revisions)
176. Proteus‏‎ (11 revisions)
177. Gram-negative bacteria‏‎ (11 revisions)
178. Pasteurella‏‎ (11 revisions)
179. Indole test‏‎ (11 revisions)
180. Catalase test‏‎ (11 revisions)
181. Immunization of people with asplenia and hyposplenia‏‎ (11 revisions)
182. Infections associated with rats‏‎ (11 revisions)
183. Staphylococcus aureus decolonization‏‎ (11 revisions)
184. Immunosuppressive therapy‏‎ (11 revisions)
185. Powassan virus‏‎ (11 revisions)
186. Diabetic foot infection‏‎ (11 revisions)
187. Sarcocystis‏‎ (11 revisions)
188. Spontaneous bacterial peritonitis‏‎ (11 revisions)
189. Modified Duke criteria‏‎ (11 revisions)
190. Antimicrobial stewardship program‏‎ (10 revisions)
191. Rabies virus‏‎ (10 revisions)
192. Hepatitis A virus‏‎ (10 revisions)
193. John Cunningham virus‏‎ (10 revisions)
194. Coagulase-negative staphylococci‏‎ (10 revisions)
195. Intra-abdominal infection‏‎ (10 revisions)
196. SPICE organisms‏‎ (10 revisions)
197. Respiratory syncytial virus‏‎ (10 revisions)
198. Pediococcus‏‎ (10 revisions)
199. Borrelia recurrentis‏‎ (10 revisions)
200. CMV after solid organ transplantation‏‎ (10 revisions)
201. Acute epiglottitis‏‎ (10 revisions)
202. Ebola virus‏‎ (10 revisions)
203. Rhodotorula‏‎ (10 revisions)
204. Herpesviridae‏‎ (10 revisions)
205. Skin and soft tissue infections (SSTI) (IDSA 2014)‏‎ (10 revisions)
206. Lactobacillus‏‎ (10 revisions)
207. Encephalitis with lymphadenopathy‏‎ (10 revisions)
208. Congenital rubella‏‎ (10 revisions)
209. Moraxella‏‎ (10 revisions)
210. Congenital toxoplasmosis‏‎ (10 revisions)
211. Spinal hardware infection‏‎ (10 revisions)
212. Tests for bacterial motility‏‎ (10 revisions)
213. Burkholderia‏‎ (10 revisions)
214. Cidofovir‏‎ (10 revisions)
215. Rickettsia conorii‏‎ (10 revisions)
216. Febrile neutropenia‏‎ (10 revisions)
217. Ganciclovir‏‎ (10 revisions)
218. Dematiaceous molds‏‎ (10 revisions)
219. Trypanosoma‏‎ (10 revisions)
220. Rickettsia prowazekii‏‎ (10 revisions)
221. Fosfomycin‏‎ (10 revisions)
222. Clostridium septicum‏‎ (10 revisions)
223. Viral hemorrhagic fever‏‎ (10 revisions)
224. Dengue virus‏‎ (10 revisions)
225. Streptococcus anginosus group‏‎ (10 revisions)
226. Neonatal HSV‏‎ (10 revisions)
227. Norovirus‏‎ (9 revisions)
228. HIV-hepatitis C coinfection‏‎ (9 revisions)
229. Septic arthritis‏‎ (9 revisions)
230. Imaging in osteomyelitis‏‎ (9 revisions)
231. Yeast and yeast-like organisms‏‎ (9 revisions)
232. Drug fever‏‎ (9 revisions)
233. Variola virus‏‎ (9 revisions)
234. Free-living amoebae‏‎ (9 revisions)
235. Opioid use disorder‏‎ (9 revisions)
236. Lung abscess‏‎ (9 revisions)
237. Encephalitis‏‎ (9 revisions)
238. Chromobacterium violaceum‏‎ (9 revisions)
239. Amphotericin B‏‎ (9 revisions)
240. Vertebral osteomyelitis‏‎ (9 revisions)
241. Antiretroviral resistance in HIV‏‎ (9 revisions)
242. Sterilization and disinfection‏‎ (9 revisions)
243. Dermatophytes‏‎ (9 revisions)
244. Enterococcus bacteremia‏‎ (9 revisions)
245. Human papillomavirus‏‎ (9 revisions)
246. Buprenorphine‏‎ (9 revisions)
247. Vibrio cholerae‏‎ (9 revisions)
248. Itraconazole‏‎ (9 revisions)
249. Rickettsia akari‏‎ (9 revisions)
250. Rat-bite fever‏‎ (9 revisions)
251. Hyponatremia‏‎ (9 revisions)
252. Nematodes‏‎ (9 revisions)
253. Salmonella enterica‏‎ (9 revisions)
254. Clostridium perfringens‏‎ (9 revisions)
255. Morganellaceae‏‎ (9 revisions)
256. Trypanosoma brucei‏‎ (9 revisions)
257. Zika virus‏‎ (9 revisions)
258. Gram-positive bacilli‏‎ (9 revisions)
259. Fungi‏‎ (9 revisions)
260. Streptococcus agalactiae‏‎ (9 revisions)
261. Eye infections‏‎ (9 revisions)
262. Staphylococcus lugdenensis‏‎ (8 revisions)
263. Neonatal tuberculosis‏‎ (8 revisions)
264. Toxoplasmosis in pregnancy‏‎ (8 revisions)
265. Pancytopenia‏‎ (8 revisions)
266. Post-infectious lactose intolerance and irritable bowel syndrome‏‎ (8 revisions)
267. CHEAP TORCHES‏‎ (8 revisions)
268. Fever and rash‏‎ (8 revisions)
269. Scedosporium‏‎ (8 revisions)
270. Hypertension‏‎ (8 revisions)
271. Antipseudomonal antibiotics‏‎ (8 revisions)
272. Kaposi sarcoma-associated herpesvirus‏‎ (8 revisions)
273. Acinetobacter‏‎ (8 revisions)
274. Clinical opioid withdrawal scale‏‎ (8 revisions)
275. Fever in a hospitalized patient‏‎ (8 revisions)
276. A Few Bacteria to Know‏‎ (8 revisions)
277. Pelvic inflammatory disease‏‎ (8 revisions)
278. Spinal epidural abscess‏‎ (8 revisions)
279. Prosthetic joint infections (PJI) (IDSA 2013)‏‎ (8 revisions)
280. Ceftolozane-tazobactam‏‎ (8 revisions)
281. Sexually-transmitted infection‏‎ (8 revisions)
282. Atypical hemolytic-uremic syndrome‏‎ (8 revisions)
283. Moraxella catarrhalis‏‎ (8 revisions)
284. Tropheryma whipplei‏‎ (8 revisions)
285. Malaria chemoprophylaxis‏‎ (8 revisions)
286. Entomophthoromycotina‏‎ (8 revisions)
287. Eosinophilia‏‎ (8 revisions)
288. Shigella‏‎ (8 revisions)
289. Foscarnet‏‎ (8 revisions)
290. Non-typhoidal Salmonella‏‎ (8 revisions)
291. Rothia mucilaginosa‏‎ (8 revisions)
292. Streptococcal toxic shock syndrome‏‎ (8 revisions)
293. Protozoa‏‎ (8 revisions)
294. Trypanosoma cruzi‏‎ (8 revisions)
295. Gram-positive bacteria‏‎ (8 revisions)
296. C-reactive protein‏‎ (8 revisions)
297. Viridans group streptococci‏‎ (8 revisions)
298. Francisella‏‎ (8 revisions)
299. CR:OCLC:978699031‏‎ (8 revisions)
300. Oxidase test‏‎ (8 revisions)
301. Rifampin‏‎ (8 revisions)
302. Marburg virus‏‎ (8 revisions)
303. Urease test‏‎ (8 revisions)
304. Post-acute sequalae of COVID-19‏‎ (7 revisions)
305. Bacterial meningitis (IDSA 2004)‏‎ (7 revisions)
306. Daptomycin‏‎ (7 revisions)
307. Trichinella‏‎ (7 revisions)
308. Modified Jones criteria‏‎ (7 revisions)
309. Staphylococcus saprophyticus‏‎ (7 revisions)
310. Streptococcus bovis group‏‎ (7 revisions)
311. Chorioamnionitis‏‎ (7 revisions)
312. Alcohol withdrawal‏‎ (7 revisions)
313. Facklamia‏‎ (7 revisions)
314. Infectious causes of dementia‏‎ (7 revisions)
315. Peritoneal tuberculosis‏‎ (7 revisions)
316. Balamuthia mandrillaris‏‎ (7 revisions)
317. Relapsing fever‏‎ (7 revisions)
318. Brucella‏‎ (7 revisions)
319. CMV after hematopoietic stem cell transplantation‏‎ (7 revisions)
320. Congenital infection clangs‏‎ (7 revisions)
321. Prednisone screening checklist‏‎ (7 revisions)
322. Drug reaction with eosinophilia and systemic symptoms‏‎ (7 revisions)
323. Dermatophilus congolensis‏‎ (7 revisions)
324. Acinetobacter baumannii complex‏‎ (7 revisions)
325. Acute retinal necrosis‏‎ (7 revisions)
326. Ascaris lumbricoides‏‎ (7 revisions)
327. CMV in pregnancy‏‎ (7 revisions)
328. Bartonella‏‎ (7 revisions)
329. Gram-negative bacilli‏‎ (7 revisions)
330. Terminal ileitis‏‎ (7 revisions)
331. Paracoccidioides brasiliensis‏‎ (7 revisions)
332. Antibiotic prophylaxis for procedures‏‎ (7 revisions)
333. Plesiomonas‏‎ (7 revisions)
334. Infections associated with natural disasters‏‎ (7 revisions)
335. Postpartum endometritis‏‎ (7 revisions)
336. A Few More Bacteria to Know‏‎ (7 revisions)
337. Burkholderia cepacia complex‏‎ (7 revisions)
338. Penicillin‏‎ (7 revisions)
339. Vibrio vulnificus‏‎ (7 revisions)
340. Bacillus‏‎ (7 revisions)
341. Klebsiella pneumoniae‏‎ (7 revisions)
342. Burkholderia mallei‏‎ (7 revisions)
343. Acquired immunodeficiency‏‎ (7 revisions)
344. Malignant otitis externa‏‎ (7 revisions)
345. Murmur‏‎ (7 revisions)
346. Culture media‏‎ (7 revisions)
347. Endophthalmitis‏‎ (7 revisions)
348. HACEK group‏‎ (7 revisions)
349. Recurrent meningitis‏‎ (7 revisions)
350. Lymphatic filariasis‏‎ (7 revisions)
351. Eosinophilic meningitis‏‎ (7 revisions)
352. Antifungal spectrum of activity‏‎ (7 revisions)
353. Gastroenteritis‏‎ (7 revisions)
354. Giardia‏‎ (7 revisions)
355. Kocuria‏‎ (7 revisions)
356. Haemophilus‏‎ (7 revisions)
357. Abiotrophia‏‎ (7 revisions)
358. Metronidazole‏‎ (7 revisions)
359. Clostridium sordellii‏‎ (7 revisions)
360. Antifungals‏‎ (7 revisions)
361. West Nile virus‏‎ (7 revisions)
362. Invasive fungal sinusitis‏‎ (7 revisions)
363. Lymphogranuloma venereum‏‎ (7 revisions)
364. Rubella virus‏‎ (7 revisions)
365. Peripartum bacteremia‏‎ (7 revisions)
366. Clostridium tetani‏‎ (7 revisions)
367. Fusarium‏‎ (7 revisions)
368. Prions‏‎ (7 revisions)
369. Gram-positive cocci‏‎ (7 revisions)
370. Parapneumonic effusion‏‎ (7 revisions)
371. Pitt bacteremia score‏‎ (6 revisions)
372. β-hemolytic streptococci‏‎ (6 revisions)
373. Hospital-acquired infection outbreak thresholds‏‎ (6 revisions)
374. Sarcoptes scabiei‏‎ (6 revisions)
375. Mycobacterium bovis‏‎ (6 revisions)
376. Arboviruses‏‎ (6 revisions)
377. Periodic fever syndrome‏‎ (6 revisions)
378. Congenital HSV‏‎ (6 revisions)
379. Gram stain‏‎ (6 revisions)
380. Respiratory infection in unimmunized hosts‏‎ (6 revisions)
381. Trichinella spiralis‏‎ (6 revisions)
382. Hepatitis B vaccine‏‎ (6 revisions)
383. Parasitic lung infections‏‎ (6 revisions)
384. Amoxicillin-clavulanic acid‏‎ (6 revisions)
385. Myiasis‏‎ (6 revisions)
386. Southern tick-associated rash illness‏‎ (6 revisions)
387. Cryptosporidium‏‎ (6 revisions)
388. Balantidium coli‏‎ (6 revisions)
389. Pseudomonas putida‏‎ (6 revisions)
390. A Few Antibiotics to Know‏‎ (6 revisions)
391. Peritonsillar abscess‏‎ (6 revisions)
392. Arthropods‏‎ (6 revisions)
393. Chromoblastomycosis‏‎ (6 revisions)
394. Microsporidia‏‎ (6 revisions)
395. Skin and soft tissue infections in the returned traveller‏‎ (6 revisions)
396. Corynebacterium jeikeium‏‎ (6 revisions)
397. Blood transfusion‏‎ (6 revisions)
398. Cardiovascular implantable electronic device (CIED) (IDSA 2017)‏‎ (6 revisions)
399. Acute rheumatic fever‏‎ (6 revisions)
400. Stevens-Johnson syndrome‏‎ (6 revisions)
401. BK virus‏‎ (6 revisions)
402. Doxycycline‏‎ (6 revisions)
403. Cheyletiella‏‎ (6 revisions)
404. Chronic active Epstein-Barr virus disease‏‎ (6 revisions)
405. Exophiala‏‎ (6 revisions)
406. Genital ulcers‏‎ (6 revisions)
407. Bartonella bacilliformis‏‎ (6 revisions)
408. Hemolytic-uremic syndrome‏‎ (6 revisions)
409. Triple sugar iron agar‏‎ (6 revisions)
410. Enterovirus‏‎ (6 revisions)
411. Metagonimus‏‎ (6 revisions)
412. Miliary tuberculosis‏‎ (6 revisions)
413. Clostridium‏‎ (6 revisions)
414. Antibiotic spectrum index‏‎ (6 revisions)
415. Yersinia enterocolitica‏‎ (6 revisions)
416. Mumps virus‏‎ (6 revisions)
417. Yersinia pestis‏‎ (6 revisions)
418. Intrinsic antibiotic resistance‏‎ (6 revisions)
419. Gram-negative cocci‏‎ (6 revisions)
420. Childhood exanthems‏‎ (6 revisions)
421. Penicillin-binding protein‏‎ (6 revisions)
422. Alternaria‏‎ (6 revisions)
423. Cimex‏‎ (6 revisions)
424. Aureobasidium‏‎ (6 revisions)
425. Outbreak investigation‏‎ (6 revisions)
426. Chronic granulomatous disease‏‎ (6 revisions)
427. Scrofula‏‎ (6 revisions)
428. Naegleria fowleri‏‎ (6 revisions)
429. Ixodes‏‎ (6 revisions)
430. Biosafety risk groups‏‎ (6 revisions)
431. Bordetella‏‎ (6 revisions)
432. Drug-drug interactions‏‎ (6 revisions)
433. Acute kidney injury‏‎ (6 revisions)
434. Pott syndrome‏‎ (6 revisions)
435. Bacteremia‏‎ (6 revisions)
436. Baylisascaris procyonis‏‎ (6 revisions)
437. Bioterrorism agents‏‎ (6 revisions)
438. Diverticulitis‏‎ (6 revisions)
439. Trematodes‏‎ (6 revisions)
440. Fibrosing mediastinitis‏‎ (6 revisions)
441. Thrombocytopenia‏‎ (6 revisions)
442. Borrelia‏‎ (6 revisions)
443. AIDS-related complex (ARC)‏‎ (6 revisions)
444. Healthcare-associated ventriculitis and meningitis (IDSA 2017)‏‎ (6 revisions)
445. Tuberculin skin test‏‎ (6 revisions)
446. Pericarditis‏‎ (6 revisions)
447. Essential thrombocythemia‏‎ (6 revisions)
448. Posaconazole‏‎ (6 revisions)
449. Infections in solid-organ transplantation‏‎ (6 revisions)
450. Cutaneous larva migrans‏‎ (6 revisions)
451. Cavitary lung lesion‏‎ (6 revisions)
452. Adenovirus‏‎ (6 revisions)
453. Implantable cardiac electric device (ICED/CIED) infections‏‎ (5 revisions)
454. Open joint injury‏‎ (5 revisions)
455. Borrelia hermsii‏‎ (5 revisions)
456. Tigecycline‏‎ (5 revisions)
457. Ornithodorus‏‎ (5 revisions)
458. Pancreatitis‏‎ (5 revisions)
459. Adrenal insufficiency‏‎ (5 revisions)
460. Chronic myeloid leukemia‏‎ (5 revisions)
461. Cladophialophora‏‎ (5 revisions)
462. Wound care‏‎ (5 revisions)
463. Spontaneous gram-negative meningitis‏‎ (5 revisions)
464. Native vertebral osteomyelitis (IDSA 2015)‏‎ (5 revisions)
465. Cutaneous tuberculosis‏‎ (5 revisions)
466. Bacterial vaginosis‏‎ (5 revisions)
467. Pseudomonas‏‎ (5 revisions)
468. Adult-onset Still's disease‏‎ (5 revisions)
469. Microbacterium‏‎ (5 revisions)
470. Ventriculitis‏‎ (5 revisions)
471. Peritoneal dialysis-associated peritonitis‏‎ (5 revisions)
472. Multidrug-resistant Gram-negative bacteria‏‎ (5 revisions)
473. Fever and petechiae‏‎ (5 revisions)
474. Mycobacterium chimaera‏‎ (5 revisions)
475. Thrombotic microangiopathy‏‎ (5 revisions)
476. Opioid pain medications‏‎ (5 revisions)
477. HIV-tuberculosis coinfection‏‎ (5 revisions)
478. Campylobacter coli‏‎ (5 revisions)
479. Oseltamivir‏‎ (5 revisions)
480. Rhizopus‏‎ (5 revisions)
481. Acute necrotizing encephalopathy‏‎ (5 revisions)
482. Urine drug testing‏‎ (5 revisions)
483. Streptococcus mitis‏‎ (5 revisions)
484. Lumbar puncture‏‎ (5 revisions)
485. Peritonitis‏‎ (5 revisions)
486. Campylobacter ureolyticus‏‎ (5 revisions)
487. Tocilizumab‏‎ (5 revisions)
488. Osler's triad‏‎ (5 revisions)
489. Congenital parvovirus‏‎ (5 revisions)
490. Flucytosine‏‎ (5 revisions)
491. Isavuconazole‏‎ (5 revisions)
492. Dientamoeba fragilis‏‎ (5 revisions)
493. Hand hygiene‏‎ (5 revisions)
494. Vascular graft infection‏‎ (5 revisions)
495. Cystic fibrosis‏‎ (5 revisions)
496. Psoas abscess‏‎ (5 revisions)
497. Hantavirus‏‎ (5 revisions)
498. Revised Clinical Institute Withdrawal Assessment for alcohol‏‎ (5 revisions)
499. Hepatitis E virus‏‎ (5 revisions)
500. Chronic Lyme disease‏‎ (5 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)